Viewing Study NCT03113812

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-26 @ 10:44 PM

Ignite Modification Date: 2026-04-06 @ 2:59 PM

Study NCT ID: NCT03113812

Status: COMPLETED

Last Update Posted: 2017-04-14

First Post: 2017-04-04

Is Gene Therapy: True

Has Adverse Events: False

Brief Title: Repeated Subcutaneous Administration of ABvac40 in Mild to Moderate Alzheimer's Disease Patients

Sponsor: Araclon Biotech S.L.

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module References Module